The Price of Hope: How One Company is Rewriting the Rules of Cancer Treatment in Amaravati

Beyond the Horizon: The Enduring Promise of CAR T-Cell Therapy for Myeloma

The Myeloma Revolution: How New Science is Redefining Hope and Care

A New Dawn in India's Cancer Fight: How Indigenous Gene Therapy is Rewriting the Rules of Hope

The Dawn of a New Era: India's Own Cancer Revolution Takes Hold

A Universal Weapon Against Breast Cancer: UCLA Scientists Unveil Groundbreaking Immunotherapy

A Father's Heart-Wrenching Plea: 'Give My Son a Chance to Live!'

Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape

Bristol Myers Squibb's Abecma Delivers Breakthrough Results in Multiple Myeloma Study

From Relapse to Remarkable Recovery: How AI and CAR T-Cell Therapy Gave a Farmer a New Lease on Life

Cero Therapeutics' Cancer Drug Gets FDA Fast Track, Yet Stock Plummets: Unpacking the Market's Paradox

Sarcoma's Silent Threat: Unveiling Hope Through Early Detection and Revolutionary Therapies

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

CARsgen Therapeutics Unveils Stellar 2025 Interim Achievements: A Deep Dive into Innovation and Growth